IN THE NEWS
Omega-3s and Other Vitamins May Improve Dry Eye
Insider, January 14, 2021
Covid: Eyesight Risk Warning from Lockdown Screen Time
BBC, January 12, 2021
Unseen Crisis Emerges as Patients Delay Medical Care During the Pandemic
PBS Newshour, December 29, 2020
DED can cause pain, blurriness, and inflammation, can even injure your cornea, and recent studies demonstrate that the damage doesn’t stop there. They reveal that individuals with DED find it harder to perform simple tasks such driving or getting dressed; experience significant pain that interferes with social relationships; and report increased anxiety, depression, and poor overall health. Experts estimate that more than 340 million adults globally and 34 million in the United States live with this condition.
David A. Antonetti, PhD, is the Roger W. Kittendorf Research Professor of Ophthalmology and Visual Sciences at the University of Michigan Kellogg Eye Center. His research areas include angiogenesis and vascular diseases as well as diabetes and metabolic disorders. More specifically, he investigates the formation and loss of the blood-brain and blood-retinal barriers with the goal of developing new treatments for diabetes-related vision loss.
“Glaucoma: Clinical Practice and Research to Optimize Patient Outcomes,” March 11, 12:00pm ET
This Congressional Briefing, from AEVR’s Research Saving Sight, Restoring Vision initiative, will feature clinician scientist-educators Mona Kaleem, MD and Elyse Joelle McGlumphy, MD, who will speak about glaucoma and their respective clinical experiences in treating patients, as well as their research efforts to better understand and optimize the patient experience. For more information, download the flyer (PDF).